NEVRO CORP's ticker is and the CUSIP is 64157FAC7. A total of 27 filers reported holding NEVRO CORP in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $3,427,000 | – | 2,500,000 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Myriad Asset Management Ltd. | 10,000,000 | $15,644,000 | 3.40% |
| Perceptive Advisors | 9,000,000 | $141,822,000 | 2.07% |
| DeepCurrents Investment Group LLC | 14,430,000 | $22,483,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 12,000,000 | $18,784,000 | 0.46% |
| Polar Asset Management Partners Inc. | 17,500,000 | $27,302,000 | 0.37% |
| ZAZOVE ASSOCIATES LLC | 1,320,000 | $2,063,000 | 0.27% |
| WOLVERINE ASSET MANAGEMENT LLC | 16,000,000 | $24,947,000 | 0.22% |
| Context Capital Management, LLC | 500,000 | $768,000 | 0.17% |
| Context Partners Fund, L.P. | 500,000 | $768,000 | 0.17% |
| PFM Health Sciences, LP | 2,000,000 | $3,151,000 | 0.15% |